Ken Haas

Ken Haas is a Biotechnology Advisor and Board Member based in San Francisco, California, with a background in private equity, venture capital, and corporate development. With experience as a CEO at multiple biotech companies and a Partner at Abingworth, he brings expertise in strategic partnerships and restructuring to his current role advising and serving on boards in the biotechnology sector. Highlights of Ken Haas' career include serving as CEO at Protein Mechanics and Aulix Biopharma, as well as his role as a Partner at Abingworth, where he contributed to investment decisions and strategic growth in the biotech industry.